Is Gvoke Approved for Kids?
Gvoke (glucagon injection) is FDA-approved for emergency treatment of severe hypoglycemia in pediatric patients aged 2 years and older who weigh at least 15 kg (33 lbs). It comes in prefilled syringe and autoinjector forms dosed by weight: 0.5 mg for kids 15-30 kg and 1 mg for those over 30 kg.[1]
What About Kids Under 2 or Lighter Weights?
Gvoke lacks approval for children under 2 years or those under 15 kg. In these cases, clinicians often use standard glucagon kits (e.g., Glucagon Emergency Kit), which allow dose adjustments down to 0.5 mg or less via syringe reconstitution. Off-label use of Gvoke may occur but isn't recommended without medical guidance.[1][2]
How Does Gvoke Compare to Other Glucagon Options for Kids?
| Option | Ages/Weights Approved | Ease of Use | Key Notes |
|--------|-----------------------|-------------|-----------|
| Gvoke (syringe/autoinjector) | 2+ years, ≥15 kg | Ready-to-use, no mixing | Faster administration; nasal form (Baqsimi) alternative for ages 4+.[1] |
| Glucagon Emergency Kit | All ages, adjustable | Requires reconstitution | Standard for infants; cheaper but more steps.[2] |
| Baqsimi (nasal glucagon) | 4+ years, any weight ≥10 kg | Nasal spray | No needles; approved for broader pediatric use but pricier.[3] |
Gvoke targets school-age kids with type 1 diabetes for quick caregiver use, unlike kits needing prep time.
Common Parent Concerns with Gvoke in Kids
Side effects mirror adults: nausea, vomiting (more frequent post-injection), headache. Rare hypersensitivity possible. Store at room temp; discard after 12 months or use-by date. Caregivers train via demo videos; it's covered by most insurance for peds with prescriptions.[1][4]
Who Makes Gvoke and Availability?
Manufactured by Xeris Pharmaceuticals. Available by prescription at pharmacies; generic absent due to patents (e.g., U.S. Patent 10,456,441 expires ~2033).[1][5] No pediatric-specific shortages reported recently.
[1]: Gvoke Prescribing Information (FDA)
[2]: American Diabetes Association Pediatric Guidelines
[3]: Baqsimi Prescribing Information (FDA)
[4]: Xeris Gvoke Patient Resources
[5]: DrugPatentWatch.com - Gvoke Patents